Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
36059 | 87 | 34.4 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
677 | 2 | PROTEASOME//UBIQUITIN//PROTEASOME INHIBITOR | 13186 |
36059 | 1 | UBCH10//UBE2C//UBE2Q1 | 87 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | UBCH10 | authKW | 6533705 | 25% | 85% | 22 |
2 | UBE2C | authKW | 2359387 | 13% | 61% | 11 |
3 | UBE2Q1 | authKW | 789714 | 3% | 75% | 3 |
4 | E2 EPF | authKW | 701969 | 2% | 100% | 2 |
5 | UBE2Q2 | authKW | 701969 | 2% | 100% | 2 |
6 | UBIQUITIN CONJUGATING ENZYME E2C UBE2C | authKW | 701969 | 2% | 100% | 2 |
7 | APC C CYCLIN A | authKW | 350985 | 1% | 100% | 1 |
8 | BIOINFORMAT SRA ITC IRST | address | 350985 | 1% | 100% | 1 |
9 | CHIRURG N OLI | address | 350985 | 1% | 100% | 1 |
10 | CNR MED SURG | address | 350985 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1281 | 62% | 0% | 54 |
2 | Cell Biology | 141 | 22% | 0% | 19 |
3 | Pathology | 60 | 8% | 0% | 7 |
4 | Biochemistry & Molecular Biology | 31 | 20% | 0% | 17 |
5 | Reproductive Biology | 22 | 3% | 0% | 3 |
6 | Genetics & Heredity | 15 | 7% | 0% | 6 |
7 | Fisheries | 9 | 2% | 0% | 2 |
8 | Medicine, Legal | 8 | 1% | 0% | 1 |
9 | Biophysics | 3 | 3% | 0% | 3 |
10 | Biochemical Research Methods | 1 | 2% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOINFORMAT SRA ITC IRST | 350985 | 1% | 100% | 1 |
2 | CHIRURG N OLI | 350985 | 1% | 100% | 1 |
3 | CNR MED SURG | 350985 | 1% | 100% | 1 |
4 | DEV BIOL ZOOL 3 | 350985 | 1% | 100% | 1 |
5 | DIPARTIMENTO FISIOPATOL RIPRODUZ UMANA | 350985 | 1% | 100% | 1 |
6 | DIPARTIMENTO MOL | 350985 | 1% | 100% | 1 |
7 | E EIGHT YEAR PROGRAM | 350985 | 1% | 100% | 1 |
8 | ILHA FUNDAO A | 350985 | 1% | 100% | 1 |
9 | IST ENDOCRINOL ONCOL SPERIME ECNR | 350985 | 1% | 100% | 1 |
10 | LUTTE PAUL STRAUSS | 350985 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR BIOLOGY | 910 | 5% | 0% | 4 |
2 | NEOPLASIA | 831 | 2% | 0% | 2 |
3 | CELLULAR ONCOLOGY | 742 | 1% | 0% | 1 |
4 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 654 | 3% | 0% | 3 |
5 | PROTEOME SCIENCE | 630 | 1% | 0% | 1 |
6 | ONCOLOGY LETTERS | 577 | 3% | 0% | 3 |
7 | CANCER BIOMARKERS | 570 | 1% | 0% | 1 |
8 | MOLECULAR BIOLOGY REPORTS | 535 | 3% | 0% | 3 |
9 | JOURNAL OF MOLECULAR HISTOLOGY | 435 | 1% | 0% | 1 |
10 | BMC CANCER | 433 | 3% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | UBCH10 | 6533705 | 25% | 85% | 22 | Search UBCH10 | Search UBCH10 |
2 | UBE2C | 2359387 | 13% | 61% | 11 | Search UBE2C | Search UBE2C |
3 | UBE2Q1 | 789714 | 3% | 75% | 3 | Search UBE2Q1 | Search UBE2Q1 |
4 | E2 EPF | 701969 | 2% | 100% | 2 | Search E2+EPF | Search E2+EPF |
5 | UBE2Q2 | 701969 | 2% | 100% | 2 | Search UBE2Q2 | Search UBE2Q2 |
6 | UBIQUITIN CONJUGATING ENZYME E2C UBE2C | 701969 | 2% | 100% | 2 | Search UBIQUITIN+CONJUGATING+ENZYME+E2C+UBE2C | Search UBIQUITIN+CONJUGATING+ENZYME+E2C+UBE2C |
7 | APC C CYCLIN A | 350985 | 1% | 100% | 1 | Search APC+C+CYCLIN+A | Search APC+C+CYCLIN+A |
8 | DIFFERENTIAL CO EXPRESSION AND DIFFERENTIAL EXPRESSION | 350985 | 1% | 100% | 1 | Search DIFFERENTIAL+CO+EXPRESSION+AND+DIFFERENTIAL+EXPRESSION | Search DIFFERENTIAL+CO+EXPRESSION+AND+DIFFERENTIAL+EXPRESSION |
9 | DOMINANT NEGATIVE UBE2C | 350985 | 1% | 100% | 1 | Search DOMINANT+NEGATIVE+UBE2C | Search DOMINANT+NEGATIVE+UBE2C |
10 | E2 EPF UBIQUITIN CARRIER PROTEIN UCP | 350985 | 1% | 100% | 1 | Search E2+EPF+UBIQUITIN+CARRIER+PROTEIN+UCP | Search E2+EPF+UBIQUITIN+CARRIER+PROTEIN+UCP |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHEN, ZH , JIANG, XF , ZENG, C , ZHENG, SJ , LUO, BT , ZENG, YM , DING, RR , JIANG, HG , HE, QY , GUO, JL , ET AL (2013) HIGH EXPRESSION OF UBIQUITIN-CONJUGATING ENZYME 2C (UBE2C) CORRELATES WITH NASOPHARYNGEAL CARCINOMA PROGRESSION.BMC CANCER. VOL. 13. ISSUE . P. - | 25 | 64% | 9 |
2 | SONG, SL , CUI, L , JING, GW , LIU, CJ , (2013) INVOLVEMENT OF UBIQUITIN-CONJUGATING ENZYME E2C IN PROLIFERATION AND INVASION OF PROSTATE CARCINOMA CELLS.ONCOLOGY RESEARCH. VOL. 21. ISSUE 3. P. 121 -127 | 21 | 66% | 0 |
3 | FAHMIDEHKAR, MA , SHAFIEE, SM , EFTEKHAR, E , MAHBUDI, L , SEGHATOLESLAM, A , (2016) INDUCTION OF CELL PROLIFERATION, CLONOGENICITY AND CELL ACCUMULATION IN S PHASE AS A CONSEQUENCE OF HUMAN UBE2Q1 OVEREXPRESSION.ONCOLOGY LETTERS. VOL. 12. ISSUE 3. P. 2169 -2174 | 20 | 59% | 0 |
4 | PALUMBO, A , DA COSTA, NM , DE MARTINO, M , SEPE, R , PELLECCHIA, S , DE SOUSA, VPL , NETO, PN , KRUEL, CD , BERGMAN, A , NASCIUTTI, LE , ET AL (2016) UBE2C IS OVEREXPRESSED IN ESCC TISSUES AND ITS ABROGATION ATTENUATES THE MALIGNANT PHENOTYPE OF ESCC CELL LINES.ONCOTARGET. VOL. 7. ISSUE 40. P. 65876 -65887 | 19 | 61% | 0 |
5 | RAWAT, A , GOPAL, G , SELVALUXMY, G , RAJKUMAR, T , (2013) INHIBITION OF UBIQUITIN CONJUGATING ENZYME UBE2C REDUCES PROLIFERATION AND SENSITIZES BREAST CANCER CELLS TO RADIATION, DOXORUBICIN, TAMOXIFEN AND LETROZOLE.CELLULAR ONCOLOGY. VOL. 36. ISSUE 6. P. 459-467 | 14 | 78% | 3 |
6 | MA, RM , KANG, XX , ZHANG, GJ , FANG, F , DU, YM , LV, H , (2016) HIGH EXPRESSION OF UBE2C IS ASSOCIATED WITH THE AGGRESSIVE PROGRESSION AND POOR OUTCOME OF MALIGNANT GLIOMA.ONCOLOGY LETTERS. VOL. 11. ISSUE 3. P. 2300 -2304 | 15 | 58% | 1 |
7 | TANG, XK , WANG, KJ , TANG, YK , CHEN, L , (2014) EFFECTS OF UBIQUITIN-CONJUGATING ENZYME 2C ON INVASION, PROLIFERATION AND CELL CYCLING OF LUNG CANCER CELLS.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 15. ISSUE 7. P. 3005 -3009 | 15 | 63% | 1 |
8 | YANG, MX , QU, YY , SHI, RL , WU, XB , SU, C , HU, ZQ , CHANG, QM , LIU, SQ , PAN, GF , LEI, M , ET AL (2016) UBIQUITIN-CONJUGATING ENZYME UBCH10 PROMOTES GASTRIC CANCER GROWTH AND IS A POTENTIAL BIOMARKER FOR GASTRIC CANCER.ONCOLOGY REPORTS. VOL. 36. ISSUE 2. P. 779 -786 | 18 | 50% | 0 |
9 | DU, HY , JIE, LG , XU, WW , WU, YS , LIU, TC , LI, M , (2012) A MONOCLONAL ANTIBODY AGAINST A POTENTIAL CANCER BIOMARKER, HUMAN UBIQUITIN-CONJUGATING ENZYME E2.HYBRIDOMA. VOL. 31. ISSUE 3. P. 196-202 | 14 | 67% | 2 |
10 | MORIKAWA, T , KAWAI, T , ABE, H , KUME, H , HOMMA, Y , FUKAYAMA, M , (2013) UBE2C IS A MARKER OF UNFAVORABLE PROGNOSIS IN BLADDER CANCER AFTER RADICAL CYSTECTOMY.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. VOL. 6. ISSUE 7. P. 1367-1374 | 16 | 48% | 8 |
Classes with closest relation at Level 1 |